Search - tctmd.com

Displaying 1 - 20 of 504

Sort: Relevancy | Date

News Daily News

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

Michael O'Riordan

January 26, 2026

News Daily News

Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX

Michael O'Riordan

January 15, 2026

News Daily News

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

Yael L. Maxwell

January 14, 2026

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Conference News AHA 2025

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

Todd Neale

November 13, 2025

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Conference News ESC 2025

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

Todd Neale

September 01, 2025

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

Advertisement

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

What’s Going to Be Hot at TCT 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

Top Coronary Artery Disease News in 2024

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content